Ranked #3 in the nation for Neurology and Neurosurgery by U.S. News & World Report
Make an Appointment
News
- September 29, 2022
The Food and Drug Administration on Thursday overcame doubts from agency scientists and approved a fiercely debated drug for ALS
Topic
- September 28, 2022
Dr. Lawrence Honig, professor of neurology at Columbia University Irving Medical Center, speaks about the new Alzheimer drug trial results
Topic
- September 28, 2022
A landmark study has shown lecanemab treatment to slow the course of Alzheimer’s disease. Lecanemab is now under consideration by the FDA but is not yet approved or available commercially.
Events
- Monday, October 3, 20225:00 PM to 6:00 PM
Venue
Online Event Zoom Meeting - Thursday, October 6, 20225:00 PM to 6:00 PM
- Thursday, October 13, 20229:00 AM to 6:00 PM
